Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface | Inospin
Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface

Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface

< Back to all posts

  Biowebspin, May 01th, 2014

Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface

by David M. Andrews, Martin E. Swarbrick, Andrew T. Merritt, in Drug Discovery Today, 2014

In response to the dual challenges of increasingly risky target portfolios and realignment of traditional pharmaceutical company resources away from early-phase research and development (R&D), research groups have sought to engage across the industrial and not-for-profit divide, resulting in the emergence of many different collaborative models. Here, we describe two successful collaborations based upon shared commitment and risk. The risks and complexities of external collaboration can be mitigated by appropriate agreements and tools, but we found that it remains essential that the collaborating scientists adopt a collaborative mindset and embrace the diverse ways of working of partner organizations.

  See the article and check access: PDF-iconIf you can't access this article, do not hesitate to contact us.
[wysija_form id="1"]
This article was relevant ? Share it with your contacts clicking on the buttons below
< Back to all posts